Literature DB >> 8216929

Immunity to Toxoplasma gondii.

C S Subauste1, J S Remington.   

Abstract

Recent advances in our understanding of the immunological mechanisms involved during infection with Toxoplasma gondii include evidence for the role of different subsets of lymphocytes and cytokines in acute infection as well as in reactivation of chronic infection. The mechanisms of presentation of T. gondii antigen have been clarified recently, and animal models of toxoplasmosis that mimic disease observed in AIDS patients developed.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8216929     DOI： 10.1016/0952-7915(93)90034-p

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  18 in total

1.  The contrasting effects of CD8+ T cells on primary, established and Nippostrongylus brasiliensis-induced IgE responses.

Authors:  B J Holmes; D Diaz-Sanchez; R A Lawrence; E B Bell; R M Maizels; D M Kemeny
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii.

Authors:  M H el Kouni; V Guarcello; O N Al Safarjalani; F N Naguib
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

3.  Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.

Authors:  Omar N Al Safarjalani; Reem H Rais; Young Ah Kim; Chung K Chu; Fardos N M Naguib; Mahmoud H El Kouni
Journal:  Biochem Pharmacol       Date:  2010-06-10       Impact factor: 5.858

4.  Detection of toxoplasmosis in patients with end-stage renal disease by enzyme-linked immunosorbent assay and polymerase chain reaction methods.

Authors:  J Saki; S Khademvatan; S Soltani; H Shahbazian
Journal:  Parasitol Res       Date:  2012-09-20       Impact factor: 2.289

5.  Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris.

Authors:  Yee Ling Lau; Girija Thiruvengadam; Wei Wei Lee; Mun Yik Fong
Journal:  Parasitol Res       Date:  2011-04-01       Impact factor: 2.289

6.  Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones.

Authors:  W Däubener; C Mackenzie; U Hadding
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

7.  Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis.

Authors:  E G Lago; G S Conrado; C S Piccoli; R L Carvalho; A L Bender
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

8.  Toxoplasma secreting Cre recombinase for analysis of host-parasite interactions.

Authors:  Anita A Koshy; Ashley E Fouts; Melissa B Lodoen; Ozan Alkan; Helen M Blau; John C Boothroyd
Journal:  Nat Methods       Date:  2010-03-07       Impact factor: 28.547

9.  Uptake of nitrobenzylthioinosine and purine beta-L-nucleosides by intracellular Toxoplasma gondii.

Authors:  Omar N Al Safarjalani; Fardos N M Naguib; Mahmoud H El Kouni
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis.

Authors:  Melissa K Middleton; Alicia M Zukas; Tanya Rubinstein; Michelle Kinder; Emma H Wilson; Peijuan Zhu; Ian A Blair; Christopher A Hunter; Ellen Puré
Journal:  Infect Immun       Date:  2009-10-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.